• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明肾细胞癌中促红细胞生成素活性的调节

Regulation of Erythropoietin Activity in Clear Renal Cell Carcinoma.

作者信息

Čokić Bojana B Beleslin, Radulović Sandra Bižić, Subotički Tijana, Čokić Vladan P, Noguchi Constance T, Bojanić Nebojša, Damjanović Svetozar

机构信息

Department for Sero and Molecular Diagnostics, Institute of Virology, Vaccines and Sera "Torlak", Vojvode Stepe 458, 11221 Belgrade, Serbia.

Clinic of Hematology, University Clinical Center of Serbia, Dr Koste Todorovića, 11000 Belgrade, Serbia.

出版信息

Int J Mol Sci. 2025 Apr 17;26(8):3777. doi: 10.3390/ijms26083777.

DOI:10.3390/ijms26083777
PMID:40332447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12027659/
Abstract

Clear-cell renal cell carcinoma (ccRCC) is associated with the mutated von Hippel-Lindau (VHL) gene leading to the activation of hypoxia-inducible factor 1A (HIF1A) and subsequent overexpression of erythropoietin (EPO). We analyzed tumor and healthy tissues from 43 ccRCC patients after radical nephrectomy and cultured 786-O (biallelic inactivation) and Caki-1 (wild-type ) cells in normal (21% O) and low oxygen (3% O) with 10% and 2% fetal bovine serum (FBS). DNA sequencing, including Sanger sequencing, MLPA and LOH, revealed 27 somatic mutations of in ccRCC. HIF1A protein showed decreased or no expression in tumors compared to healthy tissue, independent of alteration. The 786-O cells showed increased HIF1A protein expression after 48 h under low oxygen and 10% FBS. EPO and erythropoietin receptor (EPOR) were significantly decreased in ccRCC without HIF1A expression. EPO mRNA increased in the 786-O cells at 3% O after 48 h, while the Caki-1 cells had low or no EPO expression. Hypoxia increased EPOR mRNA in the Caki-1 cells at 10% FBS, but decreased in the 786-O cells at 2% FBS after 48 h. JAK2/STAT5A activity was increased only in HIF1A-positive tumors. These results suggest that EPO/EPOR activation in ccRCC is mainly driven by low oxygen, not VHL regulation of hypoxia-related responses.

摘要

透明细胞肾细胞癌(ccRCC)与突变的冯·希佩尔-林道(VHL)基因相关,该基因导致缺氧诱导因子1A(HIF1A)激活,随后促红细胞生成素(EPO)过度表达。我们分析了43例接受根治性肾切除术后的ccRCC患者的肿瘤组织和健康组织,并在正常(21% O₂)和低氧(3% O₂)条件下,分别添加10%和2%胎牛血清(FBS)培养786-O(双等位基因失活)和Caki-1(野生型)细胞。包括桑格测序、多重连接探针扩增(MLPA)和杂合性缺失(LOH)在内的DNA测序显示,ccRCC中有27个体细胞突变。与健康组织相比,HIF1A蛋白在肿瘤中的表达降低或无表达,与[此处原文缺失信息]改变无关。786-O细胞在低氧和10% FBS条件下培养48小时后,HIF1A蛋白表达增加。在无HIF1A表达的ccRCC中,EPO和促红细胞生成素受体(EPOR)显著降低。786-O细胞在3% O₂条件下培养48小时后,EPO mRNA增加,而Caki-1细胞EPO表达低或无表达。在10% FBS条件下,低氧使Caki-1细胞中的EPOR mRNA增加,但在2% FBS条件下培养48小时后,786-O细胞中的EPOR mRNA减少。JAK2/STAT5A活性仅在HIF1A阳性肿瘤中增加。这些结果表明,ccRCC中EPO/EPOR的激活主要由低氧驱动,而非VHL对缺氧相关反应的调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/a58ed6414112/ijms-26-03777-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/63d83c22768e/ijms-26-03777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/12f363718e3f/ijms-26-03777-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/53fb01934224/ijms-26-03777-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/1f9c6d5b2dc0/ijms-26-03777-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/381bb1f789f8/ijms-26-03777-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/a58ed6414112/ijms-26-03777-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/63d83c22768e/ijms-26-03777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/12f363718e3f/ijms-26-03777-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/53fb01934224/ijms-26-03777-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/1f9c6d5b2dc0/ijms-26-03777-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/381bb1f789f8/ijms-26-03777-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e4/12027659/a58ed6414112/ijms-26-03777-g006.jpg

相似文献

1
Regulation of Erythropoietin Activity in Clear Renal Cell Carcinoma.透明肾细胞癌中促红细胞生成素活性的调节
Int J Mol Sci. 2025 Apr 17;26(8):3777. doi: 10.3390/ijms26083777.
2
The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.在散发性透明细胞肾细胞癌中,促红细胞生成素过表达与缺氧诱导因子-1α 和 -2α 之间 von Hippel-Lindau 肿瘤抑制基因突变的关系。
Int J Mol Med. 2010 Dec;26(6):907-12. doi: 10.3892/ijmm_00000541.
3
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.von Hippel-Lindau 肿瘤抑制蛋白通过组蛋白去甲基酶 JARID1C 调节基因表达和肿瘤生长。
Oncogene. 2012 Feb 9;31(6):776-86. doi: 10.1038/onc.2011.266. Epub 2011 Jul 4.
4
Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma.结节性硬化症复合物蛋白1的表达受散发性透明细胞肾细胞癌中VHL基因改变和HIF-1α产生的影响。
Exp Mol Pathol. 2016 Dec;101(3):323-331. doi: 10.1016/j.yexmp.2016.11.003. Epub 2016 Nov 12.
5
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.肾透明细胞癌程序性死亡配体 1 是缺氧诱导因子-2α的新的直接靶标,受 von Hippel-Lindau 基因突变状态调控。
Eur Urol. 2016 Oct;70(4):623-632. doi: 10.1016/j.eururo.2015.11.029. Epub 2015 Dec 23.
6
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.硒通过脯氨酰羟化酶 2 依赖性和 von Hippel-Lindau 非依赖性降解,抑制肾透明细胞癌细胞中低氧诱导因子 1 和 2α,从而抑制肿瘤生长。
BMC Cancer. 2012 Jul 17;12:293. doi: 10.1186/1471-2407-12-293.
7
[Activation of HIF-1α/ACLY signaling axis promotes progression of clear cell renal cell carcinoma with VHL inactivation mutation].[HIF-1α/ACLY信号轴的激活促进伴有VHL失活突变的透明细胞肾细胞癌进展]
Zhonghua Bing Li Xue Za Zhi. 2023 Dec 8;52(12):1230-1236. doi: 10.3760/cma.j.cn112151-20230915-00175.
8
Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.透明细胞肾细胞癌非转移阶段的肿瘤生物学;硬脂酰去饱和酶-1、促红细胞生成素/促红细胞生成素受体系统及缺氧相关蛋白的过表达
Tumour Biol. 2016 Oct;37(10):13581-13593. doi: 10.1007/s13277-016-5279-4. Epub 2016 Jul 28.
9
Coexpression of erythopoietin and erythopoietin receptor in sporadic clear cell renal cell carcinoma.促红细胞生成素与促红细胞生成素受体在散发性透明细胞肾细胞癌中的共表达
Cancer Biol Ther. 2006 Jun;5(6):582-5. doi: 10.4161/cbt.5.6.2709. Epub 2006 Jun 15.
10
VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma.VHL 和 HIF-1α:早期透明细胞肾细胞癌的基因变异与预后。
Med Oncol. 2014 Mar;31(3):840. doi: 10.1007/s12032-014-0840-8. Epub 2014 Jan 21.

本文引用的文献

1
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies.肾细胞癌中的缺氧诱导因子:从分子洞察到靶向治疗
Genes (Basel). 2024 Dec 24;16(1):6. doi: 10.3390/genes16010006.
2
Expression of HIF‑α and their association with clinicopathological parameters in clinical renal cell carcinoma.缺氧诱导因子-α 的表达及其与临床肾细胞癌临床病理参数的关系。
Ups J Med Sci. 2024 Mar 21;129. doi: 10.48101/ujms.v129.9407. eCollection 2024.
3
HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies.
缺氧诱导因子-1α信号传导:在肿瘤发生中的关键作用及在靶向治疗中的意义。
Genes Dis. 2023 Mar 30;11(1):234-251. doi: 10.1016/j.gendis.2023.02.039. eCollection 2024 Jan.
4
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies.透明细胞肾细胞癌治疗的最新进展:新型生物标志物与靶向治疗
Cancers (Basel). 2023 Jun 16;15(12):3207. doi: 10.3390/cancers15123207.
5
Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance.VHL/HIF-α信号通路在肾透明细胞癌进展中的下游靶点:机制与治疗意义
Cancers (Basel). 2023 Feb 19;15(4):1316. doi: 10.3390/cancers15041316.
6
The JAK/STAT signaling pathway: from bench to clinic.JAK/STAT 信号通路:从基础到临床。
Signal Transduct Target Ther. 2021 Nov 26;6(1):402. doi: 10.1038/s41392-021-00791-1.
7
The von Hippel-Lindau Tumor Suppressor Gene: Implications and Therapeutic Opportunities.希佩尔-林道肿瘤抑制基因:意义与治疗机会。
Cancer J. 2020 Sep/Oct;26(5):390-398. doi: 10.1097/PPO.0000000000000480.
8
Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells.血清剥夺会引发前列腺癌细胞对氧化应激的适应和存活。
Sci Rep. 2020 Jul 27;10(1):12505. doi: 10.1038/s41598-020-68668-x.
9
Tissue Expression of Erythropoietin Predicts Survival Rates in Clear Cell Renal Cell Carcinoma.促红细胞生成素的组织表达可预测透明细胞肾细胞癌的生存率。
Kidney Cancer. 2017 Nov 27;1(2):143-149. doi: 10.3233/KCA-170013.
10
Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma.结节性硬化症复合物蛋白1的表达受散发性透明细胞肾细胞癌中VHL基因改变和HIF-1α产生的影响。
Exp Mol Pathol. 2016 Dec;101(3):323-331. doi: 10.1016/j.yexmp.2016.11.003. Epub 2016 Nov 12.